Empros Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.73M

  • Investors
  • 2

Empros Pharma General Information

Description

Developer of an oral therapy designed to support long-term weight-loss maintenance following incretin-based therapy-induced weight reduction. The company offers a modified-release formulation combining locally active, established drugs such as orlistat and acarbose, enabling adults seeking sustained weight management after initial weight reduction improved tolerability and consistent gastrointestinal support.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nanna Svartz väg 4
  • 171 65 Solna
  • Sweden
+46 070-723
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Nanna Svartz väg 4
  • 171 65 Solna
  • Sweden
+46 070-723

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Empros Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 03-May-2023 $7.73M Completed Clinical Trials - Phase 2
4. Later Stage VC 07-Apr-2019 Completed Clinical Trials - Phase 2
3. Early Stage VC 01-Jan-2017 Completed Clinical Trials - Phase 2
2. Early Stage VC 01-Jan-2016 Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Product Development
To view Empros Pharma’s complete valuation and funding history, request access »

Empros Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Preference 50,000 $53.35 $53.35 1x $53.35 19.21%
To view Empros Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Empros Pharma Patents

Empros Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024519926-A Reduced rebound effect in subjects treated for overweight or obesity Pending 21-May-2021
CA-3219508-A1 Reduced rebound effects in subjects treated for overweight or obesity Pending 21-May-2021
EP-4340812-A1 Reduced rebound effects in subjects treated for overweight or obesity Pending 21-May-2021
US-20250127752-A1 Reduced rebound effects in subjects treated for overweight or obesity Pending 21-May-2021
WO-2022243534-A1 Reduced rebound effects in subjects treated for overweight or obesity Inactive 21-May-2021 A61P3/04
To view Empros Pharma’s complete patent history, request access »

Empros Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Empros Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flerie Venture Capital Minority
Angel (individual) Minority
To view Empros Pharma’s complete investors history, request access »

Empros Pharma FAQs

  • When was Empros Pharma founded?

    Empros Pharma was founded in 2013.

  • Where is Empros Pharma headquartered?

    Empros Pharma is headquartered in Solna, Sweden.

  • What is the size of Empros Pharma?

    Empros Pharma has 9 total employees.

  • What industry is Empros Pharma in?

    Empros Pharma’s primary industry is Drug Discovery.

  • Is Empros Pharma a private or public company?

    Empros Pharma is a Private company.

  • What is the current valuation of Empros Pharma?

    The current valuation of Empros Pharma is .

  • What is Empros Pharma’s current revenue?

    The current revenue for Empros Pharma is .

  • How much funding has Empros Pharma raised over time?

    Empros Pharma has raised $16.4M.

  • Who are Empros Pharma’s investors?

    Flerie and have invested in Empros Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process